Cantor Fitzgerald Corp.: Reiterates the Pfizer (PFE.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of 45.00 US dollars.
Zhitong FinanceApr 18 22:10
Pfizer Analyst Ratings
BenzingaApr 18 22:01
Pfizer Analyst Ratings
BenzingaApr 15 22:31
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)
TipRanksApr 15 19:40
Pfizer's Hold Rating Upheld Amid Modest Sales Outperformance and Market Uncertainty
TipRanksApr 12 17:26
Pfizer (PFE) Receives a Hold From Berenberg Bank
TipRanksApr 11 00:15
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Fusion Pharmaceuticals (FUSN)
TipRanksApr 10 19:30
Pfizer's Hold Rating Balances Vaccine Growth Potential With Competitive and Financial Challenges
TipRanksApr 10 16:57
Analysts' Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)
TipRanksApr 6 12:20
Pfizer Analyst Ratings
BenzingaApr 5 21:33
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
BenzingaApr 5 21:34
CCI, PFE: 2 High-Yield Dividend Stocks to Buy, According to Analysts
TipRanksApr 4 19:44
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target
BenzingaApr 1 20:40
Pfizer Analyst Ratings
BenzingaApr 1 20:39
Pfizer Analyst Ratings
BenzingaMar 23 00:09
Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)
TipRanksMar 22 19:40
Pfizer's Hold Rating: Balancing Pipeline Potential With Clinical and Regulatory Uncertainties
TipRanksMar 19 13:36
Pfizer (PFE) Gets a Hold From J.P. Morgan
TipRanksMar 7 15:25
Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE)
TipRanksMar 5 12:15
Pfizer Analyst Ratings
BenzingaMar 4 23:30
No Data
No Data